EULAR Recommendations: EULAR/ACR Collaborative Projects

For initiatives with international relevance, the relevant EULAR Committee seeks collaboration with the Quality of Care committee of the American College of Rheumatology (ACR). This cooperation includes the development and validation of criteria sets for the development of recommendations regarding conducting clinical trials.

EULAR and ACR strive for a transparent and collaborative relationship in order to avoid overlaps and to identify and promote synergies.

 

  • - See more at: http://www.rheumatology.org/Practice-Quality/Clinical-Support/Criteria/Call-for-Proposals#sthash.eYfSHCLR.dpuf
  • Classification criteria including the revision or revisiting of old criteria sets that are no longer working due to shifts in disease understanding or management; and
  • Response criteria for evaluating meaningful change in disease status for use in clinical trials and possibly clinical practice.
  • - See more at: http://www.rheumatology.org/Practice-Quality/Clinical-Support/Criteria/Call-for-Proposals#sthash.7slbDnDo.dpuf
  • Classification criteria including the revision or revisiting of old criteria sets that are no longer working due to shifts in disease understanding or management; and
  • Response criteria for evaluating meaningful change in disease status for use in clinical trials and possibly clinical practice.
  • - See more at: http://www.rheumatology.org/Practice-Quality/Clinical-Support/Criteria/Call-for-Proposals#sthash.7slbDnDo.dpuf
  • Classification criteria including the revision or revisiting of old criteria sets that are no longer working due to shifts in disease understanding or management; and
  • Response criteria for evaluating meaningful change in disease status for use in clinical trials and possibly clinical practice
  • - See more at: http://www.rheumatology.org/Practice-Quality/Clinical-Support/Criteria/Call-for-Proposals#sthash.7slbDnDo.dpufNote:Note: This will be the only proposal submission opportunity for joint projects of this type before spring 2018.

Ongoing and published initiatives

Scroll down this page to find a list of ongoing and published initiatives. Ongoing initiatives are placed under published initiatives as soon as official publication takes place. Each published initiative carries the name of the initiative, the convenor, the month and year of publication as well as a link to the final, published initiative.

 

Ongoing initiatives

  • ACR-EULAR classification criteria for Calcium Pyrophosphate Deposition Disease (CPDD)
    Convenor: Choi (ACR) and Abhishek (EULAR)

  • EULAR-ACR Classification Criteria for Antisynthetase Syndrome (CLASS)
    Convenor: Aggarwal (ACR), Cavagna (EULAR)

  • ACR/EULAR Classification Criteria for Antiphospholipid Syndrome
    Convenor: Erkan (ACR), Zuily (EULAR)

  • Criteria for Treatment Response for ANCA‐Associated Vasculitis
    Convenor: Peter Merkel, Gunnar Tomasson

  • EULAR-ACR classification and diagnostic criteria in primary systemic vasculitis
    Convenor: Raashid Luqmani, Richard Watts, Peter Merkel

  • Recommendations for the management of the Autoinflammatory Type-I Interferonopathies
    Convenor: R. Goldbach-Mansky, E. Demirkaya

  • Recommendations for the management of the IL-1-mediated Autoinflammatory Diseases, CAPS (FCAS, MWS and NOMID/CINCA), TRAPS, MKD and DIRA
    Convenor: M. Gattorno, E. Demirkaya, R. Goldbach-Mansky

  • Recommendations for early diagnosis and management of patients with suspected Macrophage Activation Syndrome/Hemophagocytic Lymphohistiocytosis
    Convenor: S. Canna, B. Shakoory

 

Published initiatives

  • 2019 Classification criteria for IGG4 related disease (IgG4-RD) EULAR-ACR
    Convenor: Manuel Casals, J. H. Stone
    Published: December 3
    Read this classification
     

  • 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
    Convenor: Martin Aringer, Sindhu Johnson
    Published: August 2019
    Read this classification
    Published September 2019
    Read the Correspondance
     

  • 2016 American college of rheumatology/European league against rheumatism criteria for minimal moderate, and major clinical response in juvenile dermatomyositis
    Convenor: Lisa Rider, Frederik W. Miller
    Published: March 2018
    Read this criteria
     

  • 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
    Convenor: Ingrid Lundberg, Lisa Rider
    Published ARD: October 2017
    Read this classification
    Published RMDOpen: 14 November 2017
    Read this classification
     

  • 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome
    Convenor: Simon Bowman, Caroline Shiboski
    Published ARD: October 2016
    Read this classification
     

  • 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 
    Convenor: Angelo Ravelli, Randy Cron
    Published: February 2016
    Read this classification
     

  • EULAR-ACR recommendations for the management of polymyalgia rheumatica 
    Convenor: Bhaskar Dasgupta, Eric Matteson
    Published: September 2015
    Read this recommendation

  • ACR-EULAR classification criteria for gout
    Convenor: William Taylor, Tuhina Neogi, Tim Jansen
    Published: September 2015
    Annals of the Rheumatic Diseases 2015;74:
    1789-1798
    Read this classification
     

  • 2013 classification criteria for systemic sclerosis: an American college of rheumatology (ACR)/European league against rheumatism (EULAR) collaborative initiative
    Convenor: Frank van den Hoogen, Janet Pope
    Published: October 2013
    Read this recommendation
     

  • Evaluation of best practice for reducing delay in diagnosis and treatment of inflammatory arthritis
    Convenor: Paul Emery, Vivian Bykerk
    Published: April 2012
    Read this recommendation
     

  • ACR-EULAR recommendations for determining remission in rheumatoid arthritis
    Convenor: David Felson, Maarten Boers
    Published: January 2011
    See slide deck
     

  • EULAR-ACR points to consider for reporting disease activity in RA clinical trials
    Convenor: Daniel Aletaha, Daniel Felson
    Published: October 2008
    Read this recommendation
     

 

Related Information

2021-2022 Timeline for proposal submissions

To better streamline cross-organizational processes, the ACR and EULAR have an annual deadline for proposal submissions. 

Call opens 30 March 2021

Deadline for the submission of a Declaration of Interest, 10 May 2021

See more.[*]

[*]External link